Oxandroxyl 20 - Kalpa Pharmaceuticals

Marketed as Anavar by G.D. Searle & Co. beginning in 1962, Oxandrolone earned a reputation for medical safety and broad application. Used in pediatric and adult cases of involuntary weight loss, its non-aromatizing, low-androgenic profile made it especially versatile. Though widely used, the product was withdrawn by its original manufacturer in 1989 amid concerns over sports doping. Oxandrolone returned in 1995 as Oxandrin, distributed by Bio-Technology General Corp., and was re-approved for medical use in limited, high-need cases including HIV-related muscle degradation and growth delay.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Oxandroxyl 20 by Kalpa Pharmaceuticals, consult with your doctor or healthcare professional.